Objective: Assessment of functional vitamin B 12 status in a subset of the respondents in the British National Diet and Nutrition Survey of people aged 65 y and over. Setting: National Diet and Nutrition Survey: a British nationwide cross-sectional sample of people aged 65 y and over, living either in the community or in institutions such as nursing homes, during one calendar year spanning 1994 -1995. Methods: Methylmalonic acid (MMA) concentrations were measured in plasma samples from 313 subjects (ca 14% of those originally enrolled in the survey). The results were compared with those for serum vitamin B 12 , vitamin B 12 intakes and other status and intake estimates and with socio-demographic indices. Results: Of the NDNS participants overall, 20% had serum vitamin B 12 concentrations < 150 pmol=l. In the subset studied here, 24% of free-living and 46% of institution-living participants had MMA >0.5 mmol=l. Geometric mean MMA increased with age, from 0.25 mmol=l in people aged 65 -74 y to 0.38 mmol=l in people aged 85 þ y. There was little evidence for any gender difference in MMA. It was inversely correlated with serum vitamin B 12 and with red blood cell folate; it was positively correlated directly with total homocysteine, but not significantly with serum folate or with vitamin B 12 intake. Among respondents with high MMA, a subgroup had normal serum vitamin B 12 but higher-than-average plasma urea and creatinine. Socio-demographic co-variates of MMA included receipt of State income benefits, social class of head of household, and educational attainment. These indices were not correlated with serum vitamin B 12 . Conclusions: The progressive increase in MMA with age is metabolic evidence for increasing risk of functional vitamin B 12 deficiency with increasing age in older people. There is evidence that renal function is linked to high MMA in some older people. Age and renal function are thus both important when establishing upper reference limits for MMA. The socio-demographic observations suggest a link between poverty and poor functional vitamin B 12 status in older British people.
Introduction
During the past few decades, a number of studies worldwide have demonstrated the unique value of serum or plasma methylmalonic acid (MMA) as a specific marker of functional vitamin B 12 status. Following the early studies that demonstrated the basic relationship between vitamin B 12 and MMA in man (Gompertz et al, 1967; Chanarin et al, 1973; Norman et al, 1982; Carmel, 2000) , and which established reliable assay techniques for MMA (Stabler et al, 1986) , were a number of key studies showing a surprisingly high prevalence of raised MMA levels in the plasma of older people, where it appeared to provide a more reliable indicator of functional vitamin B 12 status than serum or plasma vitamin B 12 concentrations per se (Lindenbaum et al, 1988; Rasmussen et al, 1989; Moelby et al, 1990; Joosten et al, 1993; Allen & Casterline, 1994; Lindenbaum et al, 1994; Koehler et al, 1996; Baik & Russell, 1999; Bjorkegren & Svardsudd, 1999; Herrmann et al, 2000) . Clearly, the ageing process in itself, and the increasing prevalence of age-related medical conditions that impair vitamin B 12 absorption, both increase the probability that people will become vitamin B 12 -deficient as they grow older. Functional deficiency may occur even in people whose serum vitamin B 12 concentrations are in the normal (ie reference) range (Joosten et al, 1993) .
The relationships between MMA, tHcy and cysteine are potentially important because both tHcy and cysteine (Mansoor et al, 1995; El-Khairy et al, 1999) can independently predict vascular disease risk, tHcy is increased in vitamin B 12 deficiency as one among several determinants, and the combination of serum vitamin B 12 and MMA estimates can therefore be used to distinguish the vitamin B 12 -deficiency-effects on tHcy from those of other nutrient deficiencies and influences.
The purpose of the present study was to examine vitamin B 12 , MMA and their correlates in a sample of older British people who participated in a recent National Survey of diet and nutrition (NDNS).
Subjects and methods
As part of a series of government-commissioned surveys of several age-groups of the British population in the final decade of the twentieth century, a survey of people aged 65 y and over was carried out in 1994 -1995 (Finch et al, 1998; Bates et al, 1999) . Estimates of mean daily nutrient intakes (from a 4 day weighed diet record), a sociodemographic questionnaire and a fasting blood sample for biochemical and other status measurements were included. The blood measurements included, inter alia, serum vitamin B 12 and serum and red cell folate concentrations, and a separate study examined plasma total homocysteine (tHcy) and plasma cysteine concentrations (Bates et al, 1997) . For the present study, measurements of plasma MMA concentrations were performed in two laboratories, on a subset of the remaining unused plasma samples. These measurements have enabled a comparison to be made with key sociodemographic indices as well as with other biochemical indices of micronutrient status.
The survey plan and procedures have been described in detail elsewhere (Finch et al, 1998) , therefore only a brief summary is included here. A representative cross-sectional population sample of people aged 65 y and over, living in mainland Britain, was obtained by random selection from 80 randomly selected postcode sectors. These were allocated to four sequential 3 month 'waves' between October 1994 and September 1995, thereby spanning all four seasons. People living in institutions such as nursing homes were sampled separately. Of an eligible sample of 2172 people living in the community, 944 (43%) provided a blood sample. Of a sample of 454 people living in institutions 267 (59%) provided a blood sample. The MMA assays were performed on a subset of the blood samples, comprising 256 from free-living subjects and 57 from institution-living ones.
Demographic, socio-economic and lifestyle information was obtained by questionnaire, by a trained interviewer in the respondents' homes or institution residence, and the 4 day weighed diet record was likewise supervised (Finch et al, 1998 ). An early morning, usually fasting, blood sample was taken by a trained nurse. Part was sent to a haematology laboratory; the remainder (with lithium heparin anticoagulant) was taken in a cool-box to a local hospital laboratory for immediate separation and storage of the blood fractions at 7 40 C for up to 3 months and then at 7 80 C, for up to 5 y. A wide range of status analyses was carried out at the Micronutrient Status Laboratory, formerly of the MRC Dunn Nutrition Unit and now part of MRC Human Nutrition Research. Plasma tHcy and cysteine were measured in Dr MA Mansoor's laboratory in Stavanger, Norway (Mansoor et al, 1992; Bates et al, 1997) .
MMA was measured by capillary electrophoresis (Schneede & Ueland, 1995) . The local reference range of the assay for non-elderly adults is 0.05 -0.26 mmol=l and the CV is below 10% for MMA concentration within the normal range. About half of the MMA analyses were carried out by Dr J Schneede in Bergen, Norway while the rest were performed by Dr Mansoor using an identical assay. Those performed in Bergen included all those with the lowest 3.5% and highest 3.5% of serum vitamin B 12 values; those analysed in Stavanger were randomly selected from the remainder. The mean CV% for QC samples with values between 0.05 and 0.51 mmol=l was 7.1% in Stavanger. Good agreement was obtained by comparison with a mass spectrometric method performed at the Centers for Disease Control (CDC) Atlanta, Georgia, USA (CDC-value ¼ 0.013 þ 1.142Â Stavanger-value, n ¼ 9, r 2 ¼ 0.999), and good agreement with a mass-spectrometric assay was also achieved in Bergen. The inter-assay CV in Bergen was 8% at 0.18 and 0.36 mmol=l MMA levels, and the intra-assay CV was < 5%. Participation in an external QA scheme (Moller et al, 1999) provided further evidence of validity and accuracy. To achieve inter-laboratory harmonization between the Stavanger and the Bergen data-sets, 15 of the samples were analysed (blind) in both laboratories. These exhibited a log -linear relationship (r ¼ 0.89) with an intercept indistinguishable from zero, and a slope which differed significantly (by 14%) from unity. Therefore the two sets of results, on the log scale, were harmonized to a common mean slope. Because the MMA data-set was positively skewed, all data analyses were performed after log-transformation, and transformation was also needed for most of the other biochemical indices and intake estimates. Figure 1a and b, serum vitamin B 12 and tHcy were subdivided into fifths of their distribution and the geometric mean value for each fifth was plotted against the geometric mean of the corresponding MMA values. Since the key sociodemographic characteristics of the selected subset of participants were not identical to the census population of Great Britain, for the data shown in Table 1 , an individual weighting factor was applied to the datasets from each respondent, to correct the category proportions (based on age, gender, socio-demographic status etc) to those of the census population (Finch et al, 1998) .
Permission for the survey procedures was given by the individual Local Research Ethics Committees representing each of the 80 postcode sectors included, and by the MRC Dunn Nutrition Unit's Ethics Committee. Table 1 shows the summary statistics by age-group for MMA and the corresponding serum vitamin B 12 , tHcy, plasma creatinine and urea data for free-living respondents, and for a combined group of subjects in institutions (since numbers in each age-group in the institutions were too small for separate analysis). In the free-living group, the log e (MMA) value increased progressively with age (P < 0.0001). The slope of the regression line for log e (MMA) against age was 0.019. After adjustment for age, there was no significant difference in log e (MMA) between the two genders. The high mean MMA in the institution group was consistent with the fact that 73% of them were aged 80 y or over.
Results
The mean serum vitamin B 12 concentration in the survey subset in which both serum B 12 and MMA were measured was 211 pmol=l, which was significantly lower (by 13%) than the mean of 242 pmol=l in the subset in whom serum vitamin B 12 , but not MMA, was measured. Additional comparisons were made between the biochemical, haematological and anthropometric status indices of the 'MMA' and the 'non-MMA' subsets (not shown). Folate status and tHcy concentrations did not differ between the 'MMA' and the 'non-MMA' subsets. Only eight of 61 indices exhibited significant differences between the two subsets. The adjustment from observed to census-adjusted index values so as to mirror the socio-demographic patterns of the entire UK census population (Table 1) made little difference to any of the values; therefore the selected ('MMA') subset can be considered representative of the British population as a whole, except insofar that they had slightly lower mean serum vitamin B 12 levels.
Eleven of the subjects whose MMA was measured were users of vitamin B 12 supplements. The amount ranged from 1 to 5.75 mg=day, with a median of 2 mg=day. Although their mean MMA concentration was lower than that of the subjects not using B 12 supplements (0.30 vs 0.41 mmol=l), this was not significant. Fifteen subjects were users of folic acid supplements (daily intake 88 -5000 mg=day, median 300 mg=day), but there was no significant difference in their MMA concentrations. and plasma tHcy were divided into fifths of their distribution. They and the corresponding MMA values were log e transformed, and the means were adjusted (by multiple regression) for age and plasma creatinine, and were plotted, after back-transformation, as fifths of their distribution, against MMA as the dependent variable. There were n ¼ 58 -61 pairs of values for each of the points in the upper figure and 53 -57 pairs for those in the lower one. Error bars are s.e.m. Linear regressions between log e (serum vitamin B 12 )and log e (MMA) and between log e (tHcy) and log e (MMA) were both significant at P < 0.0001. Table 2 shows the slopes and significance of the linear relationships between log e (MMA) and key status indices and nutrient intakes. MMA was inversely correlated with serum vitamin B 12 and with red cell folate, and directly correlated with plasma tHcy. However, there was no significant relationship between MMA and serum folate or plasma cysteine. The overall correlation between MMA and vitamin B 12 intake was of only borderline significance, but the participants with the lowest vitamin B 12 intakes (n ¼ 82 with intakes < 3 mg=day) had MMA concentrations significantly higher than those with vitamin B 12 intakes ! 3 mg=day (0.35 vs 0.55 mmol=l). This was not attenuated by adjustment for age, gender or domicile. Therefore, vitamin B 12 intake, as well as efficiency of absorption, influences MMA concentrations here. Figure 1 shows the relationships between MMA (as dependent variable) and serum vitamin B 12 and tHcy (as indepen- Means have been adjusted by a weighting factor, designed to correct for demographic differences between the sample and the entire British census population: see Subjects and Methods. Linear regression of the log-transformed variables against age (continuous), for the free-living group only, revealed the following relationships: for MMA, direct, P < 0.0001; for serum vitamin B 12 , P ¼ 0.14, NS; for plasma tHcy, direct, P ¼ 0.0005; for plasma creatinine, P ¼ 0.16, NS; for plasma urea, direct, P ¼ 0.0001. Working normal ranges intended to define major biochemical deficiency=functional abnormality for these indices (Finch et al, 1998 : Bates et al, 1997 Joosten et al, 1993) were: for MMA, < 0.5 mmol=l; for tHcy, < 20 mmol=l; for serum folate, >7 nmol=l; for red cell folate, >345 nmol=l; for serum vitamin B 12 , >150 pmol=l; for plasma creatinine, < 160 mmol=l, and for plasma urea, < 15 mmol=l. Table 3 shows the result of subdividing the respondents into four groups on the basis of their serum vitamin B 12 and MMA values, using cut-off values of 150 pmol=l for vitamin B 12 (cf. Sauberlich, 1999) , and 0.5 mmol=l for MMA (the observed 80th centile of MMA and the upper limit in healthy elderly people, as observed by Joosten et al, 1993) . There emerged two subgroups of subjects, both with elevated MMA values, but with characteristically different biochemical and haematological characteristics. One of these, group 3, had normal serum vitamin B 12 but raised plasma urea and creatinine concentrations, by comparison with group 1. This group had normal red cell folate and iron status indices. The other high-MMA group, (group 4), had low serum vitamin B 12 and red cell folate and raised MMA, but had normal plasma urea and creatinine. tHcy was lowest in group 1, highest in group 4, and intermediate in groups 2 and 3. None of the groups differed significantly from each other with regard to the basic haematology indices: blood haemoglobin, haematocrit or mean red cell volume. Table 4 illustrates the socio-demographic covariates of MMA. High MMA was significantly correlated with receipt of State income benefit (a marker of low income), with manual social class of the head of household, and with lower educational attainment (certificate of secondary education or above, versus none). People receiving State income benefit, those of manual social class and those with less educational attainment had the higher MMA concentrations. In a multivariate model containing age, sex and all the above socio-demographic indices, only age, receipt of State benefits and social class of head of household remained significantly correlated with MMA after backward elimination. A combination of age, receipt of State benefits, social class of head of household, log e serum vitamin B 12 and log e tHcy together explained 31% of the variation in MMA. This did not change significantly if the subjects with the poorest renal function (highest 10% of plasma creatinine and plasma urea) were excluded. None of the socio-demographic indices were strongly associated with serum vitamin B 12 .
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Discussion
The progressive increase in MMA concentrations with age (Table 1) is even more striking than the decrease in serum vitamin B 12 concentrations with age (cf. Finch et al, 1998) . Judging from the entire NDNS dataset (Finch et al, 1998) 20% of all the survey respondents had serum vitamin B 12 Significance of differences between groups by ANOVA: models were all adjusted for age (except that for age per se). Scheffe post-hoc tests showed that for tHcy, groups 1 and 3 and groups 2 and 3 could not be distinguished, nor could groups 2 and 4, but all others differed significantly from each other. For plasma urea, only group 3 differed from all other groups. For serum ferritin, only group 1 differed from both 2 and 4. Age differed between groups 1 and 4. Table 3 of the present study indicate that some elderly respondents with raised MMA levels also have abnormal plasma urea and creatinine concentration, and therefore impaired kidney function. Many other studies have also detected a link between raised blood MMA levels and impaired kidney function (Stabler et al, 1986; Rasmussen et al, 1990a, b; Joosten et al, 1993; Lindenbaum et al, 1994; Koehler et al, 1996; Norman, 1998 Norman, , 1999 van Asselt et al, 1998; Herrmann et al, 2000; Hvas et al, 2000) . According to Whitehead et al (1994) , the 97.5th centile of plasma creatinine in adults aged 25 -55 y is approximately 122 mmol=l (males) and 100 mmol=l (females), and for plasma urea it is 7.6 mmol=l (males) and 6.8 mmol=l (females). If all subjects with plasma creatinine and=or urea concentrations above these cut-off points were eliminated from the present dataset, there remained 107 men with apparently normal renal function, of whom 20% still had MMA concentrations >0.5 mmol=l, and 112 women with apparently normal kidney function, of whom 15% had MMA concentrations >0.5 mmol=l. Therefore, a substantial proportion of the high MMA concentrations in the present study are unlikely to be attributable to impaired kidney function, and are thus more likely to be due to poor vitamin B 12 status. An MMA elevation above 0.70 mmol=l is unlikely to be explained by moderately impaired renal function alone (Rasmussen et al, 1990a,b; Moelby et al, 2000) . More work is clearly needed to establish reasonable MMA reference limits in older people with partially impaired renal function.
None of the three groups with low serum vitamin B 12 or high plasma MMA or both, in Table 3 , had abnormal haemoglobin, haematocrit or mean red cell volume. Mean red cell volume may be reduced (microcytosis) by iron deficiency, which could mask any increase (macrocytosis) resulting from vitamin B 12 deficiency. However, when all subjects with low ( < 15%) transferrin saturation and=or low ( < 20 mg=l) serum ferritin were excluded from our data-set, which reduced the number of subjects from 303 to 231, the linear regression between MCV and MMA remained nonsignificant (P ¼ 0.6, NS). It is, however, of interest that, in the entire NDNS data-set with 1079 subjects, there was a significant inverse relationship between serum vitamin B 12 and mean red cell volume (P ¼ 0.025), which became even more highly significant (P ¼ 0.015) if subjects with poor iron status were omitted. This suggests that some of the respondents with low serum vitamin B 12 may have macrocytosis. Bjorkegren & Svardsudd (1999) , reported that, although MMA increases with age, it is not necessarily correlated with any abnormality of the classical haematological indices. Excessive reliance on the evidence of haematological indices may not be an efficient way of detecting incipient vitamin B 12 deficiency in older people, and better ways of monitoring functional vitamin B 12 deficiency in populations are clearly needed (Savage et al, 1994; Nilsson-Ehle, 1998) .
Respondents with low serum vitamin B 12 but normal MMA (group 2 in Table 3 ) appeared to be intermediate between group 1 and group 4 in their biochemical characteristics. Their red cell folate and serum ferritin levels were relatively low, yet they had normal MMA levels. Therefore, they appeared to have a milder vitamin B 12 deficiency than those of group 4, who had clearly raised MMA levels. Their moderately raised tHcy was presumably the result of their poor folate and vitamin B 12 status. (holo-TCII) . This normally constitutes about 10 -30% of total vitamin B 12 in serum and is filtered in the glomerulus and actively re-absorbed in the proximal tubule. An alteration in holo-TCII may not be detected by conventional vitamin B 12 assays.
As expected, in the present study a strong inverse correlation between MMA and serum vitamin B 12 was observed. There was also a strong direct correlation between MMA and tHcy and both of these correlations still remained significant after adjustment for age (and creatinine; Table 2 and Figure  1) . However, at serum vitamin B 12 concentrations above 170 pmol=l the relation between MMA and serum B 12 became non-significant. Others have estimated the minimum serum B 12 for a plateau of MMA as ca 250 pmol=l . This indicates the existence of a stable low plateau of MMA (Rasmussen et al, 1996) when the supply of vitamin B 12 is optimal.
An inverse correlation between MMA and red cell folate, but not between MMA and serum folate, was observed (Table  2) . This is consistent with literature evidence that vitamin B 12 inadequacy is associated with failure of maintenance of intracellular folate polyglutamates, followed by leakage of monoglutamate folates out of the cells (Perry et al, 1976; Chanarin, 1979) . In the NDNS survey, 15% of the free-living participants and 39% of institution-living ones had serum folate concentrations < 7 nmol=l, and similar proportions (8 and 16%, respectively) had red cell folate concentrations below 230 nmol=l (Finch et al, 1998) .
It is of interest to estimate, from the survey dataset (Finch et al, 1998) , what proportion of subjects with raised plasma tHcy may have increases that are specifically due to low vitamin B 12 status. Using a lower cut-off of 150 pmol=l for serum vitamin B 12 and an upper cut-off of 20 mmol=l for plasma total homocysteine, 83=972 (8.5%) of subjects had both low serum B 12 and high tHcy. If one then excludes all those participants with either a low serum folate ( < 7 nmol=l) or a low red cell folate ( < 230 nmol=l), then 16 still have raised tHcy, and this falls to 11 after elimination of people with moderately raised plasma creatinine and=or urea levels, as defined earlier. In this subgroup, at least, all other likely causes of raised tHcy having been excluded, this leaves low serum B 12 as the most likely remaining explanation. Clearly at least some of the raised tHcy levels seen in the NDNS respondents are likely to be attributable solely or principally to poor vitamin B 12 status.
The rather weak correlation between MMA and estimated vitamin B 12 intake (Table 2) may be explained by the fact that much of the variance of serum vitamin B 12 between individuals arises from differences in efficiency of vitamin B 12 absorption, rather than individual differences in dietary supply, except when the dietary intake is very low. In addition, it is likely that vitamin B 12 status is dependent on longterm, as distinct from short-term variations in vitamin B 12 intakes. This is also suggested by the observation that the correlation between serum vitamin B 12 and vitamin B 12 intake is relatively weak (Finch et al, 1998; Bates et al, 1999) .
The lack of any correlation between MMA and plasma cysteine (Table 2 ) supports the idea that circulating cysteine is controlled by factors that are different from those which control tHcy. This observation helps to distinguish those metabolic factors which control the sulphur amino-acids as a group, and those which control individual members of the group.
The socio-demographic correlates of MMA (Table 4) suggest that there may be important environmental factors that predict functional vitamin B 12 status in older people in Britain. There was, however, little evidence of sociodemographic influences on serum vitamin B 12 . The underlying mechanisms controlling these relationships are not well understood, and deserve further investigation.
In summary, the observations of the present study have extended our knowledge of some of the factors correlated with vitamin B 12 status and its functional index, MMA, in older British people. The observations of the present study, when combined with those of van Asselt et al, (1998) and Bjorkegren and Svardsudd (2001) , suggest that older people living in Europe may be at risk of functional vitamin B 12 deficiency. Functional B 12 deficiency in North America has also been highlighted (Pennypacker et al, 1992; Lindenbaum et al, 1994; Carmel et al, 1999; Stabler et al, 1999) , especially in Caucasians (Carmel et al, 1999; Stabler et al, 1999) . It is unlikely to be due to a simple lack of vitamin B 12 in the diet, and thus is more likely to relate to impaired absorption or retention of the vitamin, by mechanisms that remain poorly understood (Howard et al, 1998; van Asselt et al 1998) . A recent study has demonstrated a correlation between severity depression and MMA, but not serum vitamin B 12 in older American women (Penninx et al, 2000) , thus raising the possibility of subtle functional (neurological) effects of early vitamin B 12 deficiency. A high prevalence of subtle vitamin B 12 deficiency among the elderly in populations newly exposed to folate fortification of flour and other staple foods (Jacques et al, 1999) could pose new public health problems, and MMA as a sensitive marker of functional cobalamin status is likely to become an important component in their investigation. Despite the substantially increased dietary requirement for vitamin B 12 in people with impaired absorption efficiency, it seems likely that a substantial number of older people living in Britain could benefit from moderate increases in intake of this vitamin, which could be provided, for instance, by fortification of cereals.
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